Welcome to the P3 to PIII newsletter: timely news from MTIP to help you leverage public-private partnership (P3) opportunities through the SBIR/STTR programs and prepare you for Phase III commercialization success MTIP Summer SBIR Webinar Series: National Science Foundation SBIR/STTR Funding with special guest NSF SBIR/STTR program director, Rick Schwerdtfeger Join us from anywhere to learn about […]
Learn from your peers with a live case study featuring Ron Zook, CEO & Founder of Swan Valley Medical talking about his experience with technology commercialization, product development, scaling and more. TechEx team member, Toni Tease, Daniel Juliano, Director of the Technology Transfer Office at MSU, and Ann Peterson , SBIR Outreach Program manager, will […]
A research center at the University of Montana earned $22.4 million this summer and fall from the National Institutes of Health. “It’s validated that what we set up in Missoula through this Center for Translational Medicine is working to advance discoveries at the University of Montana,” said Jay Evans, center director and research professor in […]
A Montana State University technology anticipated to improve the accuracy of medical diagnoses has been licensed by FYR Diagnostics, a biotech company in Missoula. The license agreement transfers to FYR Diagnostics a molecule detection technology developed by Stephanie McCalla, assistant professor in MSU’s Chemical and Biological Engineering Department, and Tomas Gedeon, professor in the Department of Mathematical Sciences. […]
Prepare Your 2018 Omnibus Solicitation Application for Small Business Innovation Research and Technology Transfer Grants Application deadline: Sept. 5, 2018, 5:00 p.m. local time The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 […]
The New York Times editorial board recently observed: “We shouldn’t be surprised by any biotech’s failure. We should expect it. Biotechs by their nature offer the promise of disruptive breakthroughs and discoveries, but they’re mostly all-in propositions, based on one molecule or one test. Fail in a Phase III clinical trial — and a majority do — […]
Smithsonian magazine publishes story about impact of MSU alum, vaccinologist Maurice Hilleman From MSU News Service FEBRUARY 23, 2018 BOZEMAN — The work and impact of a Montana State University alumnus was featured recently in a prominent national forum. “You Should Thank Maurice Hilleman for Helping You Live Past the Age of 10”was published […]
The BIO Investor Forum is the premier event for emerging private and public companies to connect with prospective investors to make the deals that drive our industry. More than 220 investors are already registeredfor this year, with one month to go. The foundation for the success of an event of such magnitude as BIO Investor Forum rests on […]
Climbing The Funding Ladder in Research and Drug Development
Now Accepting Applications for Three ITHS Career Development Programs
Stan Abel of SiteOne Therapeutics to Serve as Chairman Of the Board of Montana’s Leading Biotechnology Innovation Organization; Jay Evans of Inimmune and Tim Layton of Genentech Elected to the Board of Directors Billings, MT – Wednesday, August 16, 2017 – The Montana BioScience Alliance recently elected three new board members and appointed new […]
Article originally posted at: http://www.montana.edu/news/17049/msu-scientist-publishes-findings-that-may-explain-how-cancerous-tumors-survive-after-treatment BOZEMAN – A Montana State University scientist recently published research that may explain how some cancerous tumors persist and continue to grow even after undergoing treatments that kill the cancerous cells. The new findings were published in June in the journal Cell Reports and come from furthering research published two years […]
